VEGFA and cancer: Inhibitingangiogenesis requires treatment with anti-angiogenic factors, ordrugs that reduce the production of pro-angiogenic factors,prevent them binding to their receptors or block their actions.Inhibition of the VEGF pathway has become the focus ofangiogenesis research as approximately 60% of malignant tumorsexpress high concentrations of VEGF.